June 1, 2026

The cannabis Schedule III move is the biggest federal policy shift the legal cannabis industry has seen since states started legalizing. Specifically, the April 23 federal order rescheduled FDA-approved cannabis products and state-licensed medical cannabis from Schedule I to Schedule III. The 60-day registration window for medical operators to file with DEA closes June 22. Furthermore, a separate June 29 administrative hearing will evaluate broader rescheduling that could pull adult-use cannabis into Schedule III within months.
Most coverage of cannabis Schedule III rescheduling focuses on tax. That’s the obvious win. Specifically, IRS Section 280E exemption pulls effective tax rates from 70 to 80 percent down to 20 to 30 percent for qualifying operators. Notably, what gets less attention is the payroll and HR transformation that follows. This post covers the operational reality of life after Schedule III, with a focus on what changes for your team, your compensation structure, your benefits, and your compliance footprint.
For the full breakdown of the June 22 registration deadline itself, read our DEA registration deadline coverage.
The April 23 order created a bifurcated federal framework that most operators have not fully digested. Specifically, two categories moved into Schedule III effective April 22: FDA-approved drug products containing marijuana, and marijuana subject to a qualifying state medical marijuana license. Furthermore, all other marijuana, including unlicensed bulk marijuana and adult-use state-program products, remains in Schedule I for now.
For HR purposes, the key consequence is that qualifying medical operators are no longer subject to the federal Schedule I framework that drove most of cannabis’s distinctive operational constraints. Notably, this means federal banking access expands, employee benefits become available through more carriers, and payroll structures align with regulated-industry norms. Additionally, the looming June 29 broader rescheduling hearing could extend these benefits to adult-use operators by Q4 2026.
For the broader regulatory landscape and other June developments, see our cannabis market update for June 2026.
Payroll under Schedule I cannabis was a workaround built on cash, specialty providers, and tax penalties most other industries do not face. Specifically, cannabis Schedule III reclassification eliminates most of those constraints for qualifying operators. Four specific changes deserve attention.
Section 280E of the IRS code prohibited cannabis operators from deducting normal business expenses like wages, benefits, and HR costs. Furthermore, this drove effective tax rates to 70 to 80 percent of net income for many operators. Specifically, the rescheduling ends 280E exposure for qualifying medical operators. Notably, the resulting tax savings typically fund HR infrastructure most operators have deferred. A mid-size operator with $5 million in revenue often sees $300,000 to $500,000 in annual savings that becomes available for hiring, retention, and compliance work.
For more on how this affects operator economics, see our cannabis labor-to-sales ratio analysis.
Many cannabis operators have run payroll through specialty providers using workarounds because traditional payroll companies refused cannabis clients. Specifically, the new Schedule III status opens federal banking pathways for qualifying medical operators. Notably, this means access to mainstream payroll providers, direct deposit through major banks, and standard ACH processing. Furthermore, the cost savings versus specialty cannabis payroll providers typically run 30 to 50 percent.
Under Schedule I, cannabis payroll faced unique federal tax complications that drove conservative withholding strategies. Specifically, under the new framework, qualifying operators move to standard federal tax treatment. Notably, this simplifies year-end reporting, W-2 generation, and quarterly tax filings. Furthermore, it reduces the specialty accounting and tax preparation costs operators have been paying.
Operators with employees across multiple cannabis states have managed compliance through state-by-state workarounds. Importantly, cannabis Schedule III reclassification creates a federal baseline that simplifies multi-state payroll considerably. Specifically, federal employment law, federal tax treatment, and federal banking now apply consistently across qualifying medical operations regardless of state.
Beyond payroll, cannabis Schedule III rescheduling changes the day-to-day HR function for qualifying operators. Specifically, the constraints that shaped cannabis HR for the last decade no longer apply in the same way.
Under Schedule I, most insurance carriers refused to write meaningful coverage for cannabis operators. Specifically, employer-sponsored health plans, dental, vision, life insurance, and 401(k) options were limited to specialty providers at premium prices. Furthermore, cannabis Schedule III status opens the door to mainstream benefits markets for qualifying operators. Notably, the competitive advantage of offering benefits comparable to adjacent industries (retail, hospitality, agriculture) directly addresses cannabis’s biggest retention problem.
Federal cannabis prohibition created candidate hesitation that limited the talent pool. Specifically, candidates with security clearances, federal contractors, and professionals with federal-tax-sensitive personal situations avoided cannabis employment. Furthermore, cannabis Schedule III rescheduling reduces these barriers for qualifying medical operators. Importantly, the effect on candidate pool depth is meaningful, particularly for senior operations and compliance roles.
For more on cannabis hiring strategy, see our complete cannabis hiring guide.
Cannabis HR compliance under Schedule I was driven by state cannabis commissions, with federal employment law applied around the edges. Specifically, under the new framework, federal standards take primary position. Notably, this means OSHA, EEOC, FLSA, FMLA, and other federal employment frameworks apply more cleanly. Furthermore, this normalizes HR practice but also raises the compliance bar. Operators who managed to state standards now need to verify federal compliance gaps.
Under Schedule I, cannabis-related background check screens were operator discretion within state limits. Specifically, drug testing policies for cannabis use were complicated by federal-state conflicts. Furthermore, the reclassification clarifies some of this for qualifying medical operators. Notably, drug testing policies, background check standards, and pre-employment screening protocols all need refresh in the first 60 days post-deadline.
For more on building defensible HR policies, read our cannabis employee handbook guide.
Cannabis as a career has been a calculated risk for ambitious operators. Specifically, the federal illegality stigma made cannabis a less obvious destination for top retail, hospitality, and operations talent. Furthermore, the rescheduling shifts the perception meaningfully. Notably, this opens the door to operators offering credible long-term career paths that compete with adjacent industries on both compensation and stability.
The first 60 days after the registration deadline will determine which operators capitalize and which fall behind. Below are seven concrete actions.
For more on planning Q3 hiring effectively, see our cannabis hiring playbook.
The rescheduling story does not end June 22. Specifically, the DEA administrative hearing beginning June 29 in Arlington, Virginia will evaluate broader rescheduling of all marijuana, including adult-use products. Furthermore, the hearing concludes no later than July 15. Notably, a favorable outcome could pull adult-use operators into the same regulatory framework medical operators now enjoy.
For adult-use operators specifically, the strategic implication is straightforward. Importantly, the operators who build Schedule III HR infrastructure now will be ready when broader rescheduling lands. The operators who wait will face the same compressed timeline medical operators are working through this week.
We work with cannabis operators on the full HR transformation that the rescheduling enables. Specifically, we cover payroll restructuring, benefits design, compliance updates, candidate pool expansion strategy, and the documentation work that supports broader rescheduling positioning. Furthermore, we do this through fractional HR engagements rather than PEO models or recruiter commissions. Notably, this means operators retain full control while we provide the senior HR partnership the transition requires.
Learn more about our cannabis HR services.
Also see our take on cannabis HR outsourcing models.
For payroll-specific support, see our payroll support service.
Specifically, cannabis Schedule III refers to the April 23, 2026 federal order that rescheduled FDA-approved marijuana drug products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. Notably, qualifying operators face significantly different federal treatment as a result.
The cannabis Schedule III registration deadline for state-licensed medical marijuana businesses to file for federal DEA registration is June 22, 2026. Specifically, the 60-day window from the April 23 order closes that day. Importantly, businesses that file within the window may continue operating under existing state licenses while DEA reviews their application.
Specifically, IRS Section 280E prohibits Schedule I and Schedule II operators from deducting normal business expenses. Furthermore, cannabis Schedule III status exempts qualifying operators from 280E. Notably, this typically drops effective tax rates from 70 to 80 percent down to 20 to 30 percent.
Not yet. Specifically, the April 23 order applied only to FDA-approved cannabis drug products and state-licensed medical marijuana. Furthermore, adult-use marijuana remains Schedule I for now. Notably, the June 29 DEA administrative hearing will evaluate whether broader rescheduling should extend to adult-use products.
Specifically, cannabis Schedule III reclassification opens federal banking access, normalizes federal tax withholding, eliminates 280E penalties, and enables mainstream payroll provider use for qualifying operators. Furthermore, these changes typically reduce payroll provider costs by 30 to 50 percent.
Five things change. Notably, employee benefits markets expand, hiring pool depth increases, federal compliance frameworks become primary, drug testing and background check policies need refresh, and credible long-term career paths become possible. Specifically, the operators who move first capitalize most.
Generally, no. Specifically, qualifying medical operators should restructure now. Furthermore, adult-use operators should prepare HR infrastructure to deploy quickly if broader rescheduling lands after the June 29 hearing. Notably, operators who wait until rescheduling completes face the compressed timeline current medical operators are working through.
Specifically, the candidate pool expands. Furthermore, federal contractors, professionals with security clearances, and adjacent-industry talent who previously avoided cannabis are now available to qualifying medical operators. Notably, Q3 2026 is the window to capitalize on this expanded pool before competitors do.
For state-level context, see our previous market update covering NY, NJ, and Minnesota.
Be the first to comment